In a high-stakes appeal to the Trump Administration, a powerful coalition of 48 employer organizations, consumer advocacy groups, and health purchasers has formally called for a federal crackdown on the Independent Dispute Resolution (IDR) process established under the No Surprises Act (NSA). The signatories—which include the American Benefits Council, Families USA, the National Alliance of Healthcare Purchaser Coalitions, and the ERISA Industry Committee—allege that a "coordinated, high-volume strategy" by a small cohort of private equity-backed providers is destabilizing the nation’s healthcare payment system.
What was designed to be a narrow, last-resort mechanism for settling payment disputes has, according to the letter submitted to the Departments of Treasury, Health and Human Services, and Labor, morphed into a "weaponized" engine of profit. The coalition argues that the resulting surge in arbitration cases is directly inflating healthcare costs for American families, driving up premiums and deductibles to sustain what they characterize as predatory billing practices.
The Evolution of the No Surprises Act: From Protection to Friction
To understand the current crisis, one must first recognize the original intent of the No Surprises Act. Passed with bipartisan support, the law was designed to protect patients from the financial trauma of "balance billing"—the practice where patients are held liable for the difference between what an out-of-network provider charges and what an insurance plan pays.
Under the NSA, patients are held harmless. If a patient visits an in-network facility but is treated by an out-of-network clinician, or receives emergency care at an out-of-network facility, they are only responsible for their in-network cost-sharing. The law mandates that insurers and providers enter a 30-day "open negotiation" period to reach an agreement on the payment rate. If they fail to reach a settlement, the dispute moves to the IDR process. In this "baseball-style" arbitration, both parties submit a final offer, and a neutral third-party arbitrator selects one.
However, the mechanism has faced immense pressure. The coalition’s letter highlights a staggering disparity between the projected and actual use of this system. While federal regulators initially estimated that the IDR process would handle approximately 17,000 cases annually, the reality has been explosive. In the first half of 2025 alone, over 1.2 million cases were initiated. This volume suggests that the IDR process is no longer a safety valve; it has become a primary business strategy.
Chronology of a Regulatory Failure
The timeline of the NSA’s implementation reveals how quickly the system was overwhelmed:
- January 2022: The No Surprises Act officially takes effect, barring surprise billing for most private health insurance plans.
- 2023–2024: Early warnings emerge from industry observers regarding the high volume of disputes. Legal challenges from provider groups further complicate the administration of the IDR process, leading to temporary pauses and backlogs.
- Early 2025: The number of arbitration filings reaches an industrial scale. Employer groups begin to notice a consistent pattern of high-dollar awards favoring providers.
- February 2026: Reports surface regarding the systematic abuse of the IDR system by large-scale provider groups, with accusations that arbitration outcomes are significantly higher than market-rate payments.
- March 2026: The coalition of 48 organizations formally petitions the Trump Administration to exert stronger oversight over IDR entities and close the loopholes enabling "bad actors" to exploit the system.
The Private Equity Connection: Data Behind the Disruption
The coalition’s letter does not mince words regarding the primary drivers of this surge. They point specifically to four companies—Team Health, Radiology Partners, SCP Health, and HaloMD—which accounted for 55% of all IDR disputes in the first half of 2025. Of these, three are heavily backed by private equity firms.
The data provided by the coalition paints a grim picture for those footing the bill:
- Win Rates: Providers currently prevail in approximately 88% of IDR cases.
- Payment Disparity: Arbitration awards are consistently reaching between 300% and 900% of the median in-network rate.
- Economic Impact: Because these inflated costs are not absorbed by the insurers, they are passed directly to employers and employees through higher monthly premiums and increased out-of-pocket costs at the point of care.
The coalition argues that these firms have simply shifted their business models. Previously, they relied on direct patient billing to extract high fees. When the NSA closed that door, these entities "pivoted to IDR," using the law’s arbitration process to achieve similar financial outcomes by forcing insurers to pay inflated rates under the guise of neutral dispute resolution.
Structural Conflicts of Interest
Beyond the volume of cases, the coalition has raised grave concerns regarding the integrity of the arbitrators themselves. The current IDR structure creates a perverse incentive for "volume over impartiality." Because IDR entities are paid per case, there is a natural incentive to prioritize efficiency and throughput over deep, substantive investigation into whether the requested payment is truly market-based.
Even more troubling are the allegations of direct conflicts of interest. The letter highlights that some private equity firms may hold simultaneous investments in both the healthcare provider groups initiating the claims and the IDR entities (or their parent companies) presiding over them. This "circular ecosystem" threatens the foundational neutrality required for a fair arbitration system. If the entities responsible for deciding the fairness of a payment have a financial interest in the success of the party filing the claim, the entire premise of the IDR process is compromised.
Implications for Healthcare Policy and the Trump Administration
The implications of this situation are vast. For the Trump Administration, the challenge is twofold: maintaining the patient-protection core of the No Surprises Act while ensuring that the administrative mechanisms of the law do not become a vehicle for massive wealth transfers from employers to private equity.
1. The Erosion of Employer-Sponsored Insurance
For American employers, the current IDR process is an existential threat to the stability of health benefits. If the costs of arbitration continue to spiral, employers may be forced to further increase cost-sharing for their workers or, in extreme cases, drop coverage options entirely. The coalition warns that the current trend is "systematically exploited at the direct expense of American employers, workers, and families."
2. The Need for Regulatory Reform
The coalition is pushing for a series of aggressive reforms, including:
- Enhanced Oversight of IDR Entities: Stricter certification requirements to ensure that arbitrators remain truly independent and free from conflicts of interest.
- Batching Limits: Tightening the rules on how multiple claims can be "batched" together, which currently allows providers to overwhelm the system with massive, simultaneous filings.
- Transparency Requirements: Mandating that IDR entities disclose any financial ties to the parties involved in the disputes.
- Limiting "Bad Actor" Access: Creating mechanisms to penalize or restrict entities that consistently initiate frivolous or high-volume disputes that lack merit.
Conclusion: A Promise at Risk
The No Surprises Act was intended to be a landmark achievement in consumer protection—a law that removed the patient from the middle of billing disputes. By all accounts, the law has succeeded in its primary goal of protecting patients from unexpected financial ruin. However, the secondary effect has been the creation of a "hidden tax" on the healthcare system.
As the letter to the administration poignantly states: "The No Surprises Act promised American patients protection from predatory billing. That promise is being broken—not by the law, but by those exploiting its implementation for profit."
The ball is now in the court of the Trump Administration. The coalition’s appeal is clear: the current trajectory is unsustainable. Without immediate intervention, the very mechanisms designed to bring order to healthcare payments will continue to facilitate a massive, systemic exploitation of the American insurance market, ultimately forcing patients and businesses to pay the price for a broken arbitration system. The administration faces the critical task of preserving the spirit of the law while dismantling the industry loopholes that have turned a consumer-friendly policy into a profit-seeking machine.
